Od rozpoznania migotania przedsionków do optymalizacji postępowania – sprawozdanie z konferencji „Arythmix” Raport konferencyjny
##plugins.themes.bootstrap3.article.sidebar##
Opublikowane:
cze 30, 2015
##plugins.themes.bootstrap3.article.main##
Abstrakt
Brak
##plugins.themes.bootstrap3.article.details##
Jak cytować
Wożakowska-Kapłon, B., & Gorczyca-Michta, I. (2015). Od rozpoznania migotania przedsionków do optymalizacji postępowania – sprawozdanie z konferencji „Arythmix”. Medycyna Faktów , 8(2(27), 88-90. Pobrano z https://journalsmededu.pl/index.php/jebm/article/view/2317
Numer
Dział
Artykuły
Copyright © by Medical Education. All rights reserved.
Bibliografia
1. Miyasaka Y., Barnes M., Gersh B. et al.: Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980-2000, and implications on the projections for future prevalence. Circulation 2006; 114: 119-125.
2. Camm A.J., Lip G.Y., De Caterina R. et al.: 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Eur. Heart J. 2012; 33: 2719-2747.
3. Flint A.C., Banki N.M., Ren X. et al.: Detection of paroxysmal atrial fibrillation by 30-day event monitoring in cryptogenic ischemic stroke: the Stroke and Monitoring for PAF in Real Time (SMART) Registry. Stroke 2012; 43(10): 2788-2790.
4. Gladstone D.J., Sharma M., Spence J.D.; EMBRACE Steering Committee and Investigators: Cryptogenic stroke and atrial fibrillation. N. Engl. J. Med. 2014; 371(13): 1260.
5. Friberg L., Skeppholm M., Terént A.: Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1. J. Am. Coll. Cardiol. 2015; 65: 225-232.
2. Camm A.J., Lip G.Y., De Caterina R. et al.: 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Eur. Heart J. 2012; 33: 2719-2747.
3. Flint A.C., Banki N.M., Ren X. et al.: Detection of paroxysmal atrial fibrillation by 30-day event monitoring in cryptogenic ischemic stroke: the Stroke and Monitoring for PAF in Real Time (SMART) Registry. Stroke 2012; 43(10): 2788-2790.
4. Gladstone D.J., Sharma M., Spence J.D.; EMBRACE Steering Committee and Investigators: Cryptogenic stroke and atrial fibrillation. N. Engl. J. Med. 2014; 371(13): 1260.
5. Friberg L., Skeppholm M., Terént A.: Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1. J. Am. Coll. Cardiol. 2015; 65: 225-232.